Inventor · disambiguated record
Wayne Kreppner
Also filed as: KREPPNER WAYNE
3 granted patents·6 pending applications·4 citations·filing 2012–2024
57Inventor score
Files withTRIMEL PHARMACEUTICALS CORP3ACERUS BIOPHARMA INC2ACERUS PHARMACEUTICALS CORP1ACERUS PHARMACEUTICALS SRL1KREPPNER WAYNE1
Top patents by PatentIndex Score
9 records- 0175US10111888B2Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderACERUS PHARMACEUTICALS SRL·Filed 2015·Granted Oct 30, 2018·2 cites·12 claims
- 0273US2025009756A1Male Testosterone Titration Methods, Male Intranasal Testosterone Bio-Adhesive Gel Formulations and Use Thereof for Treating Hypogonadism and TRTACERUS BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0371US9757388B2Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gelsKREPPNER WAYNE·Filed 2012·Granted Sep 12, 2017·2 cites·42 claims
- 0451US10668084B2Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderACERUS BIOPHARMA INC·Filed 2015·Granted Jun 2, 2020·0 cites·43 claims
- 0551US2013040922A1Intranasal 0.45% and 0.48% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderTRIMEL PHARMACEUTICALS CORP·Filed 2012·Application pending·0 cites
- 0651US2013045958A1Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderTRIMEL PHARMACEUTICALS CORP·Filed 2012·Application pending·0 cites
- 0746US2016250228A1Intranasal 0.45% and 0.48% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderACERUS PHARMACEUTICALS CORP·Filed 2015·Application pending·0 cites
- 0846US2015290217A1Male testosterone titration methods, male intranasal testosterone bio-adhesive gel formulations and use thereof for treating hypogonadism and trtTRIMEL BIOPHARMA SRL·Filed 2013·Application pending·0 cites
- 0942US2013040923A1Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderTRIMEL PHARMACEUTICALS CORP·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →